Suffering from colorectal cancer predisposes to severe COVID-19 infection
The Mrisk-Covid study, carried out at Parc Taulí, reveals that among patients with colorectal cancer and Covid-19, 21% had the disease in a serious way, a fact that occurred in 9,4% of the population. total that were infected or had symptoms compatible with SARS-Cov2. The analysis was carried out with a sample of more than 14.280 patients with Covid or suspected of having detected it between the end of February and mid-June 2020. On World Colorectal Cancer Day, these results support the importance of the early detection of this type of cancer and therefore the importance of participating in screening programs. read more